Table 2.

MicroRNA modulation and function in SGTs.

MicroRNA	SGC Subtype	Function	Levels 1	References
hsa-let-7a	SGTs	Prognostic	+	[44,55]
hsa-let7g	SGTs	Diagnostic	−	[46]
hsa-let7g-5p	SGTs	Prognostic	−	[52,56]
hsa-miR-100	SGTs	Prognostic	−	[45,52]
hsa-miR-103a-3p	PGT	Prognostic	+	[56]
hsa-miR-106	ACC	Prognostic	+	[44]
hsa-miR-106a	SGTs	Prognostic	+	[52]
hsa-miR-106b	SGTs	Prognostic	+	[52]
hsa-miR-1180	ACC	Prognostic	+	[57]
hsa-miR-1233	PGT	Diagnostic	+	[56]
hsa-miR-125a-5p	ACC	Prognostic	+	[30]
hsa-miR-125b	SGTs	Prognostic	−	[45,52]
hsa-miR-1267	PGT	Diagnostic	+	[56]
hsa-mir-132	AP ACC MEC	Prognostic	+	[48]
hsa-miR-132	PGT	Diagnostic	−	[46,48]
hsa-miR-133b	SGTs	Prognostic	+	[54]
hsa-miR-135a-5p	SGTs	Diagnostic	−	[52]
hsa-miR-140	SGTs	Prognostic	−	[46,52,55]
hsa-miR-140-5p	PGT	Diagnostic	−	[46]
hsa-miR-140-5p	SGTs	Prognostic	−	[46,52]
hsa-miR-146b	SGTs	Diagnostic	+	[47]
hsa-miR-150	ACC	Prognostic	+	[44]
hsa-miR-152	ACC	Prognostic	+	[57]
hsa-miR-15b	PGT	Diagnostic	−	[46]
hsa-mir-16	AP ACC MEC	Prognostic	+	[48]
hsa-miR-17	AP ACC MEC	Prognostic	+	[44,48]
hsa-miR-17	SGTs	Diagnostic	+	[48]
hsa-mir-181a-2	ACC	Prognostic	+	[57]
hsa-miR-1825	PGT	Diagnostic	+	[56]
hsa-mir-195	AP ACC MEC	Prognostic	−	[48]
hsa-miR-195	SGTs	Diagnostic	−	[52]
hsa-miR-195-5p	SGTs	Diagnostic	−	[52]
hsa-miR-199a	SGTs	Diagnostic	+	[47]
hsa-miR-199a-5p	SGTs	Diagnostic	+	[52]
hsa-miR-205	MEC	Prognostic	+	[54]
hsa-miR-20a	ACC	Prognostic	+	[44,52]
hsa-mir-21	ACC	Prognostic	+	[57]
hsa-miR-21	SGTs	Diagnostic	+	[47,52]
hsa-miR-211	PGT	Diagnostic	+	[56]
hsa-miR-211-3p	ACC	Prognostic	−	[45]
hsa-miR-22	MEC	Prognostic	+	[54]
hsa-mir-221	AP ACC MEC	Prognostic	−	[48]
hsa-miR-221	AP ACC MEC	Diagnostic	−	[48]
hsa-miR-222	PGT	Diagnostic	−	[46]
hsa-miR-222-3p	SGTs	Diagnostic	+	[52]
hsa-miR-222-3p	SGTs	Prognostic	+	[46,52]
hsa-miR-30e	SGTs	Diagnostic	+	[47]
hsa-miR-31	SGTs	Diagnostic	+	[47]
hsa-miR-3125	MEC	Prognostic	−	[54]
hsa-miR-3131	ACC	Prognostic	−	[45]
hsa-miR-320a	ACC	Prognostic	+	[50]
hsa-miR-320e	SGTs	Diagnostic	+	[52]
hsa-miR-345	SGTs	Diagnostic	+	[47]
hsa-miR-374	SGTs	Diagnostic	+	[56]
hsa-miR-374	SGTs	Prognostic	+	[46,52]
hsa-miR-374c	ACC	Prognostic	+	[57]
hsa-miR-375	ACC	Prognostic	−	[44,45,52]
hsa-miR-4430	ACC	Prognostic	+	[45]
hsa-miR-4487	ACC	Prognostic	+	[45]
hsa-miR-455-3p	ACC	Prognostic	+	[44]
hsa-miR-4676	ACC	Prognostic	+	[57]
hsa-miR-4717-5p	ACC	Prognostic	+	[57]
hsa-miR-486-3p	ACC	Prognostic	+	[45]
hsa-miR-5191	ACC	Prognostic	−	[45]
hsa-miR-577	PGT	Diagnostic	+	[46]
hsa-miR-582-5p	MEC	Prognostic	−	[54]
hsa-mir-6865	ACC	Prognostic	+	[57]
hsa-miR-9	AP ACC MEC	Prognostic	−	[48]
hsa-miR-9	AP ACC MEC	Diagnostic	−	[48,52]
hsa-miR-93	SGTs	Prognostic	+	[52]
hsa-miR-99a	SGTs	Prognostic	−	[45,52]
hsa-miR-99b	SGTs	Prognostic	+	[55]

¹ Expression levels compared to healthy controls and/or benign tumors if the Diagnostic value is assigned. If the Prognostic value is assigned, the level increases (+) or decreases (−) with the cancer progression.